Search Climate Insights Directory

The report argues that rapid declines in battery costs have made near-continuous solar power (24/365 generation) an economic reality in sunny regions. In cities like Las Vegas, achieving 97% reliability for a constant power supply is now cost-competitive at $104/MWh, which is cheaper than new coal and nuclear power. The analysis demonstrates that a relatively small amount of storage—approximately 17 kWh of battery for every 1 kW of stable 24-hour power—is sufficient for most sunny locations. This shift allows solar to support 24/7 clean energy contracts for energy-intensive industries and significantly reduces the need for expensive grid expansions by allowing more capacity to be installed behind existing connections.

The document defines Nature-based Solutions (NbS) as actions to protect, manage, and restore ecosystems to address societal challenges while providing biodiversity and human well-being benefits. It identifies a lack of specific NbS frameworks in South Asia but notes that existing national laws and policies in India, Bangladesh, and Nepal provide a foundation for their mainstreaming. The report categorizes NbS into five IUCN-based approaches: ecosystem restoration, issue-specific ecosystem-related, infrastructure-related, ecosystem-based management, and ecosystem-protection. It details 15 urban case studies, including the Yamuna Biodiversity Park in New Delhi, the restoration of riverine areas in Rohingya camps in Cox's Bazar, and the Green Lumbini Initiative in Nepal, highlighting the role of multidisciplinary partnerships and community engagement in achieving ecological and socio-economic resilience.

The report highlights the escalating risks of extreme heat on human health and productivity, noting that 356,000 people died from extreme heat in 2019. It argues that while cooling demand is expected to soar—with space-cooling units potentially reaching 2.5 billion by 2030—this must be managed through sustainable solutions to avoid tripling global electricity demand by 2050. The text advocates for a mix of passive cooling, nature-based solutions, and energy-efficient active cooling, supported by policies like Minimum Energy Performance Standards (MEPS) and the appointment of Chief Heat Officers in cities such as Athens and Miami Dade County.

This report examines the landscape of urban green finance in Hyderabad and Kolkata, India, mapping the flow of public and private funds toward climate change mitigation and adaptation across six key sectors, including clean energy, sustainable transportation, and waste and water management.

The report analyzes urban green finance in Hyderabad and Kolkata, finding that both cities are heavily dependent on state and central government funding. While Hyderabad has made significant progress in renewable energy and electric mobility, and Kolkata has excelled in e-bus adoption and wetland conservation, both face governance challenges due to overlapping mandates and limited financial autonomy. The study recommends harmonized climate budgeting, increased devolution of funds to urban local bodies, and the exploration of innovative financing mechanisms like green bonds and resilience bonds to bridge investment gaps.

The Battery Subscription Facility is a special purpose vehicle (SPV) designed to lower the high upfront cost of electric buses in India—which are 1.5 to 2 times more expensive than diesel buses—by providing batteries on a subscription basis. By separating the cost of the battery from the vehicle, the facility aims to reduce upfront capital expenditures for bus operators by 40-50%. The implementation is structured in three phases: a pilot phase (10-30 buses), a catalytic phase (1,000 buses), and a scale-up phase (up to 10,000 buses). The model relies on a tripartite agreement between the bus operator, the Facility, and a local financial institution (LFI), with long-term debt (8-10 years) sourced from development finance institutions (DFIs) to match the cash flow profile of electric bus operations. The facility primarily targets the corporate bus segment to minimize counterparty risk and simplify charging infrastructure installation.

The report finds that pharmaceutical production in Hyderabad continues to cause severe environmental degradation through the discharge of untreated wastewater containing heavy metals and industrial solvents. It highlights a critical link between these manufacturing practices and the spread of antimicrobial resistance (AMR), a global health threat. The document argues that Indian regulatory bodies are failing to enforce pollution controls and that the pharmaceutical industry's reliance on opaque supply chains allows companies exporting to the US and EU to avoid accountability for their environmental footprint.

The report highlights a critical lack of transparency in the antibiotic supply chain for the French market, noting that while formulation often occurs in Europe, active pharmaceutical ingredients (APIs) are primarily sourced from India and China. It documents severe environmental pollution and the proliferation of antibiotic-resistant bacteria around production sites in these countries, linking specific manufacturers like Aurobindo and Mylan to these impacts. The document argues that current French public procurement processes fail to account for these environmental risks and calls for a global audit and stricter transparency requirements to combat antimicrobial resistance.

The report identifies pharmaceutical manufacturing as a critical third driver of antimicrobial resistance (AMR), alongside human and animal misuse. Field research in India revealed high levels of drug-resistant E. coli near factories in Hyderabad, Chennai, and Delhi, specifically linking Aurobindo Pharma, Orchid Chemicals, and Asiatic Drugs & Pharmaceuticals to these hotspots. The document details a complex global supply chain where Chinese firms produce active pharmaceutical ingredients (APIs) under poor environmental conditions, which are then processed in India and exported to Western healthcare systems, including the UK's NHS and US distributors like McKesson. It concludes that current regulatory inspections focus on product safety rather than environmental impact, allowing pollution to accelerate a global health crisis.

The report details the presence of antibiotic-resistant bacteria near pharmaceutical production sites in India and China, arguing that poor waste management in these hubs fuels the global spread of 'superbugs'. Through water sampling and supply chain analysis, it identifies specific companies—such as Aurobindo Pharma, Orchid Chemicals, and Asiatic Drugs and Pharmaceuticals—as 'AMR hotspots' and traces their products to major healthcare providers and pharmaceutical giants in the West.

The report identifies a critical link between irresponsible pharmaceutical manufacturing practices in China and India and the proliferation of 'superbugs'. Field sampling in India revealed high levels of antibiotic resistance in water sources near factories owned by Aurobindo Pharma, Orchid Chemicals, and Asiatic Drugs and Pharmaceuticals. The analysis shows that these polluting sites are integrated into global supply chains, providing active pharmaceutical ingredients (APIs) and finished drugs to major distributors and healthcare providers in the West, including McKesson in the US and various public hospitals in France. The document argues that antimicrobial resistance is driven by three factors—medical, agricultural, and industrial—and calls for the integration of environmental criteria into Good Manufacturing Practices (GMP) and greater supply chain transparency.

The report identifies pharmaceutical manufacturing waste in India and China as a significant driver of antimicrobial resistance (AMR). Through water sampling in India and supply chain analysis, it links specific polluting factories to major global distributors and public health systems, including the UK's NHS. It argues that current Good Manufacturing Practice (GMP) frameworks are insufficient because they lack environmental criteria, allowing 'superbugs' to proliferate and spread globally via trade and travel.

The document examines how the pharmaceutical industry contributes to the global rise of 'superbugs' through the discharge of antibiotic-laden waste into the environment, particularly in China and India. It highlights a critical lack of transparency in the supply chain and argues that current Good Manufacturing Practices (GMP) fail to include environmental criteria. The report provides case studies of specific companies—such as NCPC, CSPC, and Aurobindo—linked to environmental violations and calls on German health authorities (BfArM) and procurement bodies (BVBG) to integrate environmental and AMR criteria into their licensing and purchasing processes to prevent the further spread of drug-resistant bacteria.

The report documents severe water and soil contamination caused by the bulk drug industry in India, particularly in Telangana and Andhra Pradesh. It highlights a systemic failure of waste treatment infrastructure and regulatory oversight, linking local pollution to the global spread of antimicrobial resistance (AMR). The investigation identifies major pharmaceutical companies, including Aurobindo, Dr Reddy's, Hetero, and Mylan, as significant polluters whose products enter global markets, while local communities suffer from chronic health issues and destroyed livelihoods.

The report documents systematic pharmaceutical pollution in India, particularly in the bulk drug manufacturing hubs of Hyderabad and Visakhapatnam. It argues that the discharge of active pharmaceutical ingredients (APIs) into waterways contributes to the global threat of antimicrobial resistance (AMR) and causes severe local health and environmental degradation. The document highlights a failure of regulatory oversight and a lack of supply chain transparency, which allows multinational pharmaceutical companies to outsource production to polluting sites without accountability. It recommends integrating environmental standards into the Good Manufacturing Practice (GMP) framework and increasing transparency in supplier relationships.

The report argues that the pharmaceutical industry is fueling the antimicrobial resistance (AMR) crisis through the unmonitored dumping of antibiotic-laden waste into the environment during the production of active pharmaceutical ingredients (APIs). It highlights a 'three-tier chain' where raw materials from China are processed in India and then sold to global markets. The document identifies specific polluting factories in China—including NCPC, CSPC/Inner Mongolia Changsheng, and Sinopharm—and links them to major companies such as Pfizer, Teva, and McKesson. It concludes that current Good Manufacturing Practices (GMP) are insufficient because they lack environmental criteria, and calls for greater supply chain transparency and the integration of environmental protection into global pharmaceutical standards.

The Uniform World Model (UWM) is a simplified environmental impact assessment tool designed to calculate health impacts and damage costs from air pollution. It uses a few key input parameters and assumes a uniform distribution of receptors to provide a transparent alternative to complex 'black-box' software. The author validates the UWM by comparing its results with established models like CALPUFF, ISC3, EMEP, and GAINS across various scales and regions, including Europe, China, India, and the USA. Findings indicate that the UWM is robust, typically falling within a ±50% deviation range, and is particularly accurate for regional or continental estimates and tall stack emissions.

The document outlines the tension between a 'narrow view' of internet governance, focused on critical internet resources, and a 'broader view' that links technical decisions to development outcomes. It details the proposed agenda for the 2008 Hyderabad meeting, specifically the 'Reaching the next billion' theme, and highlights the role of Dynamic Coalitions in addressing the digital divide, human rights, and linguistic diversity. The International Institute for Sustainable Development (IISD) specifically argues for the inextricable link between internet evolution and global sustainability.

The document discusses the tension between aesthetic and functional choices in urban greening across Indian cities, noting that many commonly planted exotic species are prone to uprooting during extreme weather events like cyclones. It highlights a lack of scientific rigour in national guidelines and fragmented institutional management of urban greenery, while weighing the biodiversity benefits of native species against the perceived hardiness of non-native species in urban environments.

The research examines the challenges of impact-driven investing in new mobility enterprises in Kampala and Hyderabad. It identifies systemic barriers, including regulatory risks, entrenched stakeholders, and the difficulty of quantifying transport-related impacts due to the sector's indirect role in other development areas. The paper argues that successful impact investing requires stakeholders to understand market and institutional barriers and commit to supportive partnerships.